MAIA Biotechnology, Inc. — Form D

MAIA Biotechnology, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-29. The offering totals $4.9M, of which $4.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Steven M ChaoukiDirectorChicago, IL
Ramiro M GuerreroDirectorChicago, IL
Ngar Yee LouieDirectorChicago, IL
Cristian Yee LuputDirectorChicago, IL
Stan M SmithDirectorChicago, IL
Jean-Manasse C TheageneDirectorChicago, IL
Sergei M GryaznovExecutive OfficerChicago, IL
Jeffrey C HimmelreichExecutive OfficerChicago, IL
Louie Ngar YeeDirectorChicago, IL
Steven ChaoukiDirectorChicago, IL
Stan SmithDirectorChicago, IL
Sergei GryaznovExecutive OfficerChicago, IL
Jeffrey HimmelreichDirectorChicago, IL
Jeffrey HimmelreichExecutive OfficerChicago, IL
Vlad VitocDirectorChicago, IL
Vlad VitocExecutive OfficerChicago, IL
Ramiro GuerreroDirectorChicago, IL
Jean-Manasse TheageneDirectorChicago, IL
Cristian Ngar LuputDirectorChicago, IL
Stan V SmithDirectorChicago, IL
Cristian V LuputDirectorChicago, IL
Ngar Yee V LouieDirectorChicago, IL
Ramiro V GuerreroDirectorChicago, IL

Other filings by this issuer (6)

FiledFormOfferingSold
2026-01-05D$2.0M$1.5M
2025-10-14D$7.0M$3.0M
2025-06-11D$8.0M$695K
2025-03-04D$5.9M$4.1M
2024-11-12D$15.5M$2.4M
2024-03-21D$5.7M$2.9M

More